Crossing the chasm: caution for use of angiotensin receptor-neprilysin inhibition in patients with cardiogenic shock– a case report

BACKGROUND: Vasoplegia has been reported in patients receiving angiotensin receptor-neprilysin inhibitors (ARNI) with heart failure with reduced ejection fraction (HFrEF). We present a case of vasoplegic shock after initiation of ARNI in a hospitalized 65-year-old man recovering from cardiogenic sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Almazroa, Loai, Mihajlovic, Vesna, Lawler, Patrick R., Luk, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793177/
https://www.ncbi.nlm.nih.gov/pubmed/33442637
http://dx.doi.org/10.1093/ehjcr/ytaa233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793177/
https://www.ncbi.nlm.nih.gov/pubmed/33442637
http://dx.doi.org/10.1093/ehjcr/ytaa233

Ejemplares similares